Anthraquinone glycoside 0.5 % / salicylic acid 1 % Mucous Membrane Topical Solution
RxNorm 106119
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 106119 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: anthraquinone glycoside 0.5 % / salicylic acid 1 % Mucous Membrane Topical Solution.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SCD
Semantic Clinical Drug (SCD):
Anthraquinone glycoside 5 mg/ML / salicylic acid 10 mg/ML Mucous Membrane Topical Solution
(Atom ID: 12335918)
PSN
Prescribable Name (PSN):
Anthraquinone glycoside 0.5 % / salicylic acid 1 % Mucous Membrane Topical Solution
(Atom ID: 6393399)
SY
Synonym (SY):
Anthraquinone glycoside 0.5 % / salicylic acid 1 % Mucous Membrane Topical Solution
(Atom ID: 3318013)
PT
Designated preferred name (PT):
Anthraquinone glycoside 5 mg/mL and salicylic acid 10 mg/mL oromucosal solution
(Atom ID: 11435312)
FN